Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.11 AUD | -2.08% | -2.71% | -18.21% |
08:50am | Healthcare, IT Lead Losses on Australian Bourse | MT |
07:47am | Lendlease Chair to Step Down Amid Board Reset | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- The company's attractive earnings multiples are brought to light by a P/E ratio at 8.8 for the current year.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.66 for the current period. Therefore, the company is undervalued.
- The company's share price in relation to its net book value makes it look relatively cheap.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company does not generate enough profits, which is an alarming weak point.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Real Estate Development & Operations
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-18.21% | 2.85B | B | ||
+17.32% | 29.15B | B- | ||
-5.15% | 27.94B | B | ||
+26.23% | 26.02B | B- | ||
+16.84% | 24.95B | A- | ||
+40.97% | 22.49B | A- | ||
+20.06% | 22.19B | A | ||
-4.42% | 18.48B | B- | ||
+2.83% | 16.73B | B+ | ||
+22.53% | 15.89B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- LLC Stock
- Ratings Lendlease Group